Once-Weekly Semaglutide Reduces HbA(1c) and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2–4 and 10

INTRODUCTION: Despite treatment with oral antidiabetic drugs (OADs), achieving effective glycaemic control in type 2 diabetes (T2D) remains a challenge. The objective of this post hoc analysis of data from the SUSTAIN 2, 3, 4 and 10 active-controlled trials was to assess the efficacy and safety of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Capehorn, Matthew, Ghani, Yasmin, Hindsberger, Charlotte, Johansen, Pierre, Jódar, Esteban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193006/
https://www.ncbi.nlm.nih.gov/pubmed/32193837
http://dx.doi.org/10.1007/s13300-020-00796-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193006/
https://www.ncbi.nlm.nih.gov/pubmed/32193837
http://dx.doi.org/10.1007/s13300-020-00796-z

Ejemplares similares